May 2012

Quantitative MR model may shed light on prostate cancer aggressiveness ()
Stroke: Optimal care could lop millions from costs annually ()
Feature: Inappropriate PCI use varies, patient selection needs improvement ()
Maquet acquires Avalons catheter ()
PE overdiagnosis: Is CTA sparking an epidemic? ()
Looking for a lead after recalls ()
The ice cream stand syndrome ()
Circ: Cardiac mortality ranking systems are imprecise ()
Circ: Telemonitoring improves HF patients' quality of life, utilization ()
Echo: A Leader in TAVR Planning ()
TAVR: A Sound Investment or a Siren Song? ()
Q&A | Breaking the Code for Vascular Surgery Reimbursement ()
PET: Making the Numbers Work ()
Sex Appeal: Heart Centers Cater to Women ()
HRS Hits Beantown in High Fashion ()
Rivaroxaban for ACS: Dead or alive? ()
ATLAS shrugged off: FDA panel rejects rivaroxaban for ACS patients ()
Medtronic sees double-digit gains in FY12, Q4 ()
ATLAS ACS trial in hot seat at FDA panel, mainly about missing data ()
EHJ: Multidisciplinary CRT care improves patient outcomes ()
Circ: DES can reduce TVR, but it depends on eluting drug ()
Survey: Volume remains thorn in cath labs side ()
JACC: Post-PCI bleeds reduced by 20%, not due to radial approach ()
Feature: Changing cath lab shortcomings into long-term gains ()
Making PCI safe for operators ()
Abiomed skips into black for FY12 ()
NEJM: Common antibiotic linked to a few CV deaths, prompting FDA review ()
Lancet: Bad news for HDLs rep as the good cholesterol ()
Report: Med device industry making the right moves in face of global frugality ()
Radiology: Contrast-enhanced US could cut EVAR follow-up risks ()
HRS: Off-guideline ICD use for primary prevention may not cause harm ()
HRS: Anti-arrhythmics for VT/ICD: Do the benefits outweigh the risks? ()
HRS: RAFT shows CRT-D is cost-effective + improves quality of life ()
HRS: Mind the gap: ICD variation remains unexplained ()
SCAI: Cell therapy expert puts perspective on recent heart research ()
HRS: Watchman still strong for stroke prevention, even without warfarin ()
HRS: To have or to holdanticoagulation use during device procedure ()
CSC: Don't discount social media; you'll need it ()
Perminova, LifeWatch align to expand interoperability in cardiology ()
HRS: LAA closure may be good alternative for high-risk AF patients ()
HRS: Apixaban may be new ARISTOTLE for AF, no matter what type ()
HRS: Hitting the spotEcho-guided lead placement improves CRT outcomes ()
HRS: Atrial overdrive pacing fails to ASSERT itself in AF prevention ()
SCAI: Iliac stents gain MOBILITY in treatment of PAD ()
HRS: Ablation superior to antiarrhythmic drugs as first-line therapy for AF ()
SCAI: Robotic-assisted PCI is safe for patients, safer for operators ()
HRS: Revising ICD leads during elective surgery may save money, cut risk ()
Empire State practice taps Fuji for PACS ()
HRS: EP NPs spend a large amount of time on device clinic services ()
HRS: Hospitals save using remote ICD monitoring strategy ()
FDA: Controversial stenting treatment for MS may endanger patients ()
HRS: Patients not swayed from ICD generator change because of cost, device advisory ()
HRS: Study shows Riata leads worse off in terms of survival ()
HRS: Quantifying sympathetic denervation could provide new approach to identifying arrhythmic death ()
HRS: More data lean in favor of S-ICD system ()
HRS: ICD therapy shows benefit at long-term follow-up ()
HRS: NID 30/40 detection window safe in reducing unnecessary ICD therapy ()
SCAI: Are new technologies for renal artery stenting worth the cost? ()
HRS: Statins help reduce AF risk in elderly ()
HRS: Who falls into the ICD gap and why do disparities still exist? ()
SCAI: Where and how angio falls short in the cath lab ()
SCAI: Phoning the patient can lead to near-perfect DAPT adherence ()
HRS: Women respond better to CRT, but we still don't know why ()
SCAI: Best bailout strategy for radial failures? Switch sides ()
MetroHealth electrophysiologist Rosenbaum passes away ()
HRS: CRT-D reduces risk for women with nonischemic heart disease ()
AIM: False STEMI activations lead to costs, inappropriate cath lab use ()
HRS: Reprogramming reduces inappropriate shocks for ICD patients ()
Stroke: Primary stroke centers are cost effective in most scenarios ()
Roche ditches dalcetrapib, due to disappointing trial results ()
JAMA: Older women with afib have greatest risk of stroke ()
Circ: Cards fail to control elevated BP in 30% of hypertensive patients ()
AATS: Study questions insulin protocols for CABG patients ()
Lilly sees slight dip in Q1 ()
JACR: What practices should know about professional component MPPR ()
Covidien reports strong growth in Q2 ()
McKesson posts double-digit gains in Q4, FY2012 ()
AIM: BMS or DES for STEMI? Jury may still be out ()
JAMA feature: Most clinical trials fail to add meaningful evidence ()
AR: CTA uncovers CAD in young diabetics ()
Feature: Unite! CV emergency care system across the U.S. may be in order ()
AHA: Is ECMO the wave of the future? ()
AIM: Five strategies help hospitals improve AMI performance ()